Azienda Sanitaria Locale Della Provincia Di Biella — Clinical Trial Site

35 Registered trials

17 Currently recruiting

Organisation

Azienda Sanitaria Locale Della Provincia Di Biella

Location

Ponderano, Italy

Identifier

ORG-100048063

Address

Via Dei Ponderanesi 2, 13875, Italy

Departments

Addictions
Hematology
Medical oncology
Neurology
Oncologia
Oncology
Ospedale degli Infermi di Biella - SC Oncologia
Pathology of Addiction
S.C. Neurologia
S.C. Oncologia
S.C. Oncologia - Ospedale Degli Infermi
S.O.C. Oncologia
S.S.D. Ematologia
SC di Oncologia
SC Oncologia
SCDU Pediatria e Neonatologia
SOC Neurologia
SOC Oncologia
SSD Ematologia
Struttura complessa di Neurologia
UO Oncologia
UOC Cardiologia

Clinical trials at this site (35)

Search interface

MITO 25.1: A randomized, molecular driven phase II trial of Carboplatin-Paclitaxel-Bevacizumab vs Carboplatin-Paclitaxel-Bevacizumab-Rucapar… Ended

2024-516632-99-00 Advanced (stage III B-C-IV) ovarian, primary peritoneal 4 2021-03-17
Comparison of two strategies that use the same drugs but with inverted sequence for the treatment of patients with metastatic colorectal can… Ended

2024-513296-41-00 Colorectal cancer spread at distance, RAS BRAF wild typ 4 2020-12-03
A study to determine whether the addition of Dostarlimab (TSR-042) delays recurrence of advanced endometrial cancer Ended

2023-506551-23-00 Recurrent or primary advanced (Stage III or IV) endomet 5 2019-11-21
Clinical study of ibrutinib and rituximab in untreated marginal zone lymphomas Ended

2023-507886-25-00 Previously untreated and symptomatic patients with hist 4 2019-09-27
A Phase II study of post-operative palbociclib as an alternative to chemotherapy in older patients with localized breast cancer at high risk… Ended

2023-505223-31-00 Localized ER+ breast cancer 4 2019-06-14
STUDY COMPARING TWO STANDARD TREATMENTS IN AUTOLOGOUS STEM CELL TRANSPLANTATION INELIGIBLE POPULATION AFFECTED BY MULTIPLE MYELOMA (Dara-VM… Ended

2024-512049-17-00 Newly diagnosed MM patients >= 65 years old or ineligib 6 2018-09-05
A randomized phase III multicenter trial assessing efficacy and toxicity of a combination of Rituximab and Lenalidomide (R2) vs Rituximab al… Ended

2024-511640-11-00 Follicular lymphoma 5 2014-05-15
A Double-Blind, Randomized, Multicenter, Trial Evaluating the Efficacy and Safety of PRAX-628 in Adults with Focal Seizures (POWER 1) Ended

2024-514559-13-00 Focal Epilepsy 10 2024-11-26
A Long-term Extension Study to Evaluate Safety, Tolerability, and Efficacy of AL002 in Alzheimer's Disease Ended

2023-506872-29-00 Alzheimer's Disease 4 2023-04-13
Study of Nemvaleukin Alfa in Combination with Pembrolizumab Versus Investigator's Choice Chemotherapy in Patients with Platinum-Resistant Ep… Ended

2024-513230-38-00 Platinum-Resistant Epithelial Ovarian, Fallopian Tube, 5 2022-12-15
THIS IS A CLINICAL STUDY WHICH EVALUATES TREATMENT WITH CHLORAMBUCIL AND RITUXIMAB FOLLOWED BY RITUXIMAB GIVEN UNDER THE SKIN IN PATIENTS W… Ended

2023-507291-52-00 Extranodal Marginal Zone Lymphoma 4 2014-03-24